Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sign up freePricing

Cambridge Innovation Capital (Jersey) Limited investment portfolio

Cambridge Innovation Capital (Jersey) Limited has made numerous investments in companies such as Immutrin, Storm Therapeutics, and Riverlane within the Biotech sector.

vc
Portfolio
5
Team
0

Portfolio (5)

CompanySectorCitySourceLast confirmed on
Immutrin Ltd
Immutrin Ltd is a biotechnology company developing a next‑generation antibody therapy that selectively removes systemic amyloid deposits, with its lead asset aimed at treating ATTR cardiomyopathy, a serious form of amyloidosis.
BiotechHealth Tech
CambridgeConfirmed2025-09-19
Microbiotica Limited
Microbiotica develops precision microbiome medicines, delivering live bacterial therapeutics and diagnostic biomarkers for inflammatory bowel disease, immuno‑oncology and gut epithelial barrier repair. It partners with pharmaceutical companies and academic research institutions to advance these products toward clinical use.
Healthcare & Life SciencesCambridgeConfirmed2025-07-07

Sign up to see the full portfolio

+3 more companies

Sign up

Shareholding changes (4)

Cambridge Innovation Capital (Jersey) Limited's positions across portfolio companies
2025
2023

Sign up free to see when this investor has bought or sold shares.

+2 more changes

Sign up

Articles (2)